Details for New Drug Application (NDA): 072134
✉ Email this page to a colleague
NDA 072134 describes PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE, which is a drug marketed by Chartwell Rx, Fosun Pharma, Ivax Sub Teva Pharms, Mylan, Par Pharm, Sun Pharm Industries, and Watson Labs, and is included in thirty-five NDAs. It is available from one supplier. Additional details are available on the PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE profile page.
The generic ingredient in PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE is amitriptyline hydrochloride; perphenazine. There are thirteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the amitriptyline hydrochloride; perphenazine profile page.
The generic ingredient in PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE is amitriptyline hydrochloride; perphenazine. There are thirteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the amitriptyline hydrochloride; perphenazine profile page.
Summary for 072134
| Tradename: | PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE |
| Applicant: | Watson Labs |
| Ingredient: | amitriptyline hydrochloride; perphenazine |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 25MG;4MG | ||||
| Approval Date: | Feb 15, 1989 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
